Liability Suit Over Generic Reglan Won’t Include Wyeth, Schwarz

Liability for labeling of a generic version of Wyeth and Schwarz Pharma’s Reglan doesn’t include the innovators, a district court says in a summary judgment. The U.S. District Court for the Southern District of West Virginia dismissed the innovator companies from a lawsuit that would have held them responsible for inadequate warning of potential adverse events suffered by a patient taking a generic version of their product, which is indicated to treat gastroesophageal reflux disease. The companies did not manufacture the product that injured the plaintiff, according to court documents.
Generic Line